Login / Signup

MYC translocation is a valuable marker for the development and relapse of extramedullary disease in multiple myeloma.

Yuhang SongJianhua DuXianghong JinHui LiCongwei JiaYuanyuan LiuKaimi LiDaobin ZhouJunling Zhuang
Published in: European journal of haematology (2024)
Soft-tissue EMD can be considered a high-risk condition, even in the era of novel agents. MYC translocation can serve as a valuable marker that correlates with extramedullary spread and relapse in patients with MM and should be considered for inclusion in routine FISH panels in clinical practice.
Keyphrases
  • clinical practice
  • soft tissue
  • multiple myeloma
  • free survival
  • transcription factor